Ross L Levine
Works at
Sloan-kettering Inst Can Research
Member26 May 2026reporter.nih.gov
Grants and prizes
R01Clonal hematopoiesis as a targetable mechanism of resistance to therapy in thyroid cancer.R01CA3039582026–203126 May 2026reporter.nih.gov
Sloan-kettering Inst Can Research
Member26 May 2026reporter.nih.gov
R01Clonal hematopoiesis as a targetable mechanism of resistance to therapy in thyroid cancer.R01CA3039582026–203126 May 2026reporter.nih.gov